Fenofibrate Fenofibrate is a hypolipidemic compound. PPARα (peroxisome proliferator-activated receptor α) agonist (EC50=18 μM for mouse and EC50 = 30 μM for human PPARα).

Fenofibrate  (CAS 49562-28-9)

Fenofibrate is rated 5.0 out of 5 by 1.
  • 2016-10-21T12:01CST
  • bvseo_cps, prod_bvrr, vn_cps_3.4.0
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_204751, PRD, sort_relevancy
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getAggregateRating, 6ms
| See 4 Citations
Synonym: Procetofen; Trilipix
Application: A hypolipidemic PPARα agonist
CAS Number: 49562-28-9
Purity: ≥98%
Molecular Weight: 360.83
Molecular Formula: C20H21ClO4
* Refer to Certificate of Analysis for lot specific data (including water content).
Submit a review for this product and receive 15 CruzCredits

Ordering Information

Fenofibrate sc-204751 5 g $34.00

Fenofibrate is a hypolipidemic compound which acts as a peroxisome proliferator-activated receptor α (PPARα) agonist (EC50 = 18 μM for mouse and EC50 = 30 μM for human). Fenofibrate also binds to PPARγ with at least 10-fold less affinity, and is inactive at PPARδ at concentrations up to 100 μM.


Inhibition of membrane-bound hepatic 3 hydroxy-3 methyl glutaryl CoA reductase as the consequence of altered membrane fluidity: E. Wulfert, et al.; Artery 9, 120 (1981) Fenofibrate protects lipoproteins from lipid peroxidation: synergistic interaction with alpha-tocopherol: E. Chaput, et al.; Lipids 34, 497 (1999) Effects of chronic treatment with statins and fenofibrate on rat skeletal muscle: a biochemical, histological and electrophysiological study: S. Pierno, et al.; Br. J. Pharmacol. 149, 909 (2006) In vitro and in vivo effects of the PPAR-alpha agonists fenofibrate and retinoic acid in endometrial cancer: S.A. Saidi, et al.; Mol. Cancer 5, 13 (2006) PPARalpha agonist fenofibrate suppresses tumor growth through direct and indirect angiogenesis inhibition: D. Panigrahy, et al.; PNAS 105, 985 (2008)

Appearance :
Physical State :
Solubility :
Soluble in acetone, ether, DMSO (15 mg/ml), DMF (30 mg/ml), ethanol (1 mg/ml), methanol (slightly soluble), benzene, chloroform, DMF:PBS (1:3 pH 7.2) (0.25 mg/ml), ethyl acetate, acetonitrile, and hexane. Insoluble in water.
Storage :
Store at -20° C
Melting Point :
79-83° C
Boiling Point :
469.77° C at 760 mmHg (Predicted)
Density :
1.18 g/cm3 (Predicted)
Refractive Index :
n20D 1.55 (Predicted)
IC50 :
Dopamine transporter: IC50 = 8.63 µM (human); Acetylcholinesterase: IC50 = 15.55 µM (human); LoVo: IC50 = 13.2 µM (human); Serotonin 2a receptor: IC50 = 2.12 µM (human); ADORA3 protein: IC50 = 5.7 µM (human); Peroxisome proliferator-activated receptor alpha: IC50 = 1 µM (human); PPARα: EC5050 = 18 µM (murine); PPARα: EC5050 = 30 µM (human)
Ki Data :
ADORA3 protein: Ki= 3.22 µM (human); Serotonin 2c receptor: Ki= 1.24 µM (human); Fatty acid-binding protein, liver: Ki= 0.41 µM (rat)
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
WGK Germany :
PubChem CID :
Merck Index :
14: 3978
MDL Number :
EC Number :

Download SDS (MSDS)

Certificate of Analysis

Adobe Acrobat Reader is required to reliably view,
print and comment on PDF documents

You May Also Like

Fenofibrate Product Citations

See how others have used Fenofibrate. Click on the entry to view the PubMed entry .

Citations 1 to 4 of 4 total

PMID: # 26872613
Rotondi, S. et al. 2016. Expression of Peroxisome Proliferator-Activated Receptor alpha (PPARα) in somatotropinomas: Relationship with Aryl hydrocarbon receptor Interacting Protein (AIP) and in vitro effects of fenofibrate in GH3 cells. Mol. Cell. Endocrinol..

PMID: # 26617775
Zuo, N. et al. 2015. Fenofibrate, a PPARα agonist, protect proximal tubular cells from albumin-bound fatty acids induced apoptosis via the activation of NF-kB. Int J Clin Exp Pathol. 8: 10653-61.

PMID: # 25881202
Ann, SJ. et al. 2015. PPARα agonists inhibit inflammatory activation of macrophages through upregulation of β-defensin 1. Atherosclerosis. 240: 389-97.

PMID: # 23747828
Petrescu, AD. et al. 2013. High glucose potentiates L-FABP mediated fibrate induction of PPARα in mouse hepatocytes. Biochim. Biophys. Acta. 1831: 1412-25.

Citations 1 to 4 of 4 total
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getContent, 99ms
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
Rated 5 out of 5 by from Wu Wu, Y. et al. (PubMed 26387199) used Fenofibrate, a PPAR agonist, to demonstrate that PPAR- can negatively regulate cardiomyocyte hypertrophy. -SCBT Publication Review
Date published: 2015-03-14
  • 2016-10-21T12:01CST
  • bvseo_cps, prod_bvrr, vn_cps_3.4.0
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_204751, PRD, sort_relevancy
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getReviews, 6ms

Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2016 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.